BIG
VERA icon

Brooklyn Investment Group’s Vera Therapeutics VERA Stock Holding History

Brooklyn Investment Group’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-214
Closed -$5.04K – 2609
2025
Q2 		$5.04K Sell
214
-787
-79% -$17.7K ﹤0.01% 2465
2025
Q1 		$24K Buy
1,001
+954
+2,030% +$30.7K 0.01% 1071
2024
Q4 		$1.99K Buy
+47
New +$2.08K ﹤0.01% 1457

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brooklyn Investment Group's VERA Position: Q3 2025 in Review

Brooklyn Investment Group sold out of Vera Therapeutics (VERA) in Q3 2025, closing a stake of 214 shares — an estimated $5.04K sold.

Brooklyn Investment Group first reported a position in VERA in Q4 2024 and held it in 3 quarters. The position peaked at $24K in Q1 2025. 175 funds tracked by Wall St. Rank hold VERA as of Q3 2025.

  • Brooklyn Investment Group reported no remaining Vera Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Brooklyn Investment Group sold 214 Vera Therapeutics shares in Q3 2025, an estimated $5.04K.
  • Brooklyn Investment Group first reported a position in Vera Therapeutics in Q4 2024 and held it in 3 quarters.
  • Brooklyn Investment Group's Vera Therapeutics position peaked at $24K in Q1 2025.
  • 175 funds tracked by Wall St. Rank held Vera Therapeutics as of Q3 2025.

Based on Brooklyn Investment Group's 13F filing for Q3 2025, filed 14 Nov 2025.